In adults, there is a growing body of literature that suggests that SGAs can precipitate increased weight gain,5,6 hyperlipidemia,7 insulin resistance,8,9 and type 2 diabetes.10–13 Type 2 diabetes is closely associated with dyslipidemia and cardiovascular disease. The long-term microvascular and macrovascular complications associated with type 2 diabetes contribute significantly to its related morbidity and mortality. The coexistence of central obesity (increased waist circumference) and at least 2 additional criteria (high blood pressure, high triglyceride level, low HDL-cholesterol level, or high fasting glucose) is referred to as the metabolic syndrome14 and is a predictor of cardiovascular disease risk. Recent data in adults with mental illness suggest that SGAs increase the prevalence of metabolic syndrome by about 5-fold.15 The combined effect of the burden of psychiatric illness and the side effects related to the medications used to treat mental illness in adults is a 19% greater mortality rate (owing in part to cardiovascular disease) than in the general population.16